Who owns TRANSCODE THERAPEUTICS INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Transcode Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Transcode Therapeutics stock

Who bought or sold TRANSCODE THERAPEUTICS INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 122k $70k 217% Sep 2024
 View chart
Sheets Smith Wealth Management 50k $29k 149% Sep 2024
 View chart
Jane Street 40k $23k 100% Sep 2024
 View chart
Private Capital Management 18k $18k 100% Jun 2024
 View chart
Captrust Financial Advisors 16k $9.3k 44% Sep 2024
 View chart
Two Sigma Securities 13k $13k -42% Jun 2024
 View chart
Morgan Stanley 10k $10k 100% Jun 2024
 View chart
Tower Research Capital 7.9k $7.9k 60% Jun 2024
 View chart
Bank of America Corporation 141.00 $81.004500 156% Sep 2024
 View chart

Who sold out of Transcode Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2024 26k $26k
Susquehanna International Jun 2024 24k $24k
Virtu Financial Jun 2024 18k $18k
Financial Network Wealth Advisors Jun 2024 1.0k $1.0k